Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Aarti Pharmalabs Ltd.
Change Company   
BSE Code 543748
ISIN Demat INE0LRU01027
Book Value 203.44
NSE Code AARTIPHARM
Dividend Yield % 0.55
Market Cap 82214.67
P/E 31.95
EPS 28.39
Face Value 5  
18-Jun-2025 Aarti Pharmalabs informs about analyst meet
12-May-2025 Grant Of Options Under PSOP Scheme 2023
29-Apr-2025 Aarti Pharmalabs informs about press release
25-Apr-2025 Aarti Pharmalab informs about board meeting
08-Apr-2025 Aarti Pharmalabs informs about compliance certifi...
01-Apr-2025 Aarti Pharmalabs informs about disclosure
07-Feb-2025 Aarti Pharmalabs informs about press release
28-Jan-2025 Aarti Pharmalabs informs about board meeting
28-Jan-2025 Aarti Pharmalabs informs about conference call
13-Jan-2025 Aarti Pharmalabs surges on entering into agreemen...
10-Jan-2025 Aarti Pharmalabs enters into agreement with Pro-z...
10-Jan-2025 Aarti Pharmalabs informs about certificate
09-Jan-2025 Aarti Pharmalabs informs about updates
30-Dec-2024 Aarti Pharmalabs informs about disclosures
17-Dec-2024 Aarti Pharmalabs informs about disclosure
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.